Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate*
- N. Fujimoto, S. Yeh, C. Chang
- BiologyThe Journal of Biological Chemistry
- 19 March 1999
TLDR
The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen Receptor
- A. Mizokami, E. Koh, M. Namiki
- Biology, MedicineCancer Research
- 15 January 2004
TLDR
Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter.
- A. Mizokami, S. Yeh, C. Chang
- BiologyMolecular endocrinology
- 1994
TLDR
Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues.
- N. Kimura, A. Mizokami, T. Oonuma, H. Sasano, H. Nagura
- Biology, MedicineThe journal of histochemistry and cytochemistry…
- 1 May 1993
TLDR
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
- K. Izumi, Lei-Ya Fang, Chawnshang Chang
- Biology, ChemistryEMBO molecular medicine
- 27 August 2013
TLDR
Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study
- K. Shigehara, K. Sugimoto, M. Namiki
- MedicineThe aging male : the official journal of the…
- 4 February 2011
TLDR
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer
- Z. Fu, Y. Kitagawa, E. Keller
- BiologyThe Prostate
- 15 February 2006
Diminished expression of Raf kinase inhibitor protein (RKIP), an inhibitor of the Raf signaling cascade, promotes prostate cancer (PCa) metastasis in a murine model, suggesting that it is a…
Epigenetic Regulation of Androgen Receptor Gene Expression in Human Prostate Cancers
- T. Nakayama, Masatoshi Watanabe, T. Shiraishi
- BiologyLaboratory Investigation
- 1 December 2000
TLDR
Novel HER2 selective tyrosine kinase inhibitor, TAK‐165, inhibits bladder, kidney and androgen‐independent prostate cancer in vitro and in vivo
- J. Nagasawa, A. Mizokami, K. Koshida, Sei Yoshida, Kenichiro Naito, M. Namiki
- Biology, ChemistryInternational journal of urology : official…
- 1 May 2006
TLDR
The establishment of two paclitaxel‐resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines
- Masashi Takeda, A. Mizokami, M. Namiki
- Biology, MedicineThe Prostate
- 15 June 2007
Although paclitaxel is used for hormone‐resistant prostate cancer, relapse definitely occurs later. Details of the molecular mechanism responsible for paclitaxel‐ resistance remain unclear.
...
...